BAYER AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 110.2 PLN | -3.01% |
|
-3.96% | -25.79% |
| 16/07 | ORIC Pharmaceuticals, Inc. Enters into Clinical Trial Collaboration and Supply Agreements with Bayer and Janssen Research & Development, LLC | CI |
| 15/07 | BAYER AG : UBS sticks Neutral | ZD |
Business Summary
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sales per Business
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Crop Science
48.8
%
| 25,169 | 49.6 % | 23,270 | 48.8 % | -7.54% |
Pharmaceuticals
38.0
%
| 19,252 | 37.9 % | 18,081 | 38.0 % | -6.08% |
Consumer Health
12.7
%
| 6,080 | 12.0 % | 6,027 | 12.7 % | -0.87% |
All Other
0.5
%
| 217 | 0.4 % | 238 | 0.5 % | +9.68% |
Enabling Functions and Consolidation
0.0
%
| 21 | 0.0 % | 21 | 0.0 % | 0.00% |
Sales per region
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
30.6
%
| 15,685 | 30.9 % | 14,587 | 30.6 % | -7.00% |
Europe/Middle East/Africa
23.2
%
| 11,352 | 22.4 % | 11,071 | 23.2 % | -2.48% |
Brazil
10.4
%
| 5,322 | 10.5 % | 4,967 | 10.4 % | -6.67% |
Asia/Pacific
10.0
%
| 5,192 | 10.2 % | 4,745 | 10.0 % | -8.61% |
Latin America
8.3
%
| 3,966 | 7.8 % | 3,961 | 8.3 % | -0.13% |
China
7.6
%
| 4,259 | 8.4 % | 3,624 | 7.6 % | -14.91% |
Germany
5.1
%
| 2,477 | 4.9 % | 2,448 | 5.1 % | -1.17% |
North America
3.5
%
| 1,886 | 3.7 % | 1,667 | 3.5 % | -11.61% |
Switzerland
1.2
%
| 600 | 1.2 % | 567 | 1.2 % | -5.50% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 01/23/01 |
| Director of Finance/CFO | 55 | 26/18/26 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/20/01 |
Christian Rommel
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/21/01 |
| - | - | ||
Heike Prinz
PRN | Corporate Officer/Principal | - | 01/23/01 |
Itziar Canamasas
PRN | Corporate Officer/Principal | 50 | - |
Ruzha Draganova
PRN | Corporate Officer/Principal | - | 01/15/01 |
Rodrigo Santos
PRN | Corporate Officer/Principal | 51 | - |
Miriam Holstein
PRN | Corporate Officer/Principal | - | 01/22/01 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 01/17/01 |
Alberto Weisser
BRD | Director/Board Member | 68 | 01/21/01 |
Paul Achleitner
BRD | Director/Board Member | 67 | 01/02/01 |
Ertharin Cousin
BRD | Director/Board Member | 67 | 01/19/01 |
| Director/Board Member | 66 | 28/20/28 | |
Heike Hausfeld
BRD | Director/Board Member | 58 | 01/94/01 |
André van Broich
BRD | Director/Board Member | 54 | 01/12/01 |
Frank Löllgen
BRD | Director/Board Member | 63 | 01/15/01 |
| Director/Board Member | 64 | 01/22/01 | |
Andrea Sacher
BRD | Director/Board Member | 43 | 01/20/01 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 982,424,082 | 982,167,123 ( 99.97 %) | 0 | 99.97 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
BAYER CROPSCIENCE LIMITED 71.43% | 32,102,999 | 71.43% | 2,597,595,223 $ |
CENTURY THERAPEUTICS, INC. 15.00% | 12,675,838 | 15.00% | 32,323,387 $ |
METAGENOMI, INC. 10.81% | 4,050,997 | 10.81% | 16,528,068 $ |
BOUNDLESS BIO, INC. 7.26% | 1,615,201 | 7.26% | 6,250,828 $ |
SENTI BIOSCIENCES, INC. 12.85% | 5,878,488 | 12.85% | 1,622,463 $ |
| 1,490,625 | 0.38% | 383,195 $ | |
AZITRA, INC. 4.54% | 1,307,401 | 4.54% | 120,281 $ |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. |
Pharmaceuticals: Major
|
Schering Berlin, Inc.
 Schering Berlin, Inc. Medical SpecialtiesHealth Technology Part of Bayer AG, Schering Berlin, Inc. is a company that manufactures pharmaceuticals and diagnostic substances. The company is based in Whippany, NJ. |
Medical Specialties
|
Wholesale Distributors
| |
Bayer Healthcare LLC
 Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. |
Pharmaceuticals: Major
|
Seminis Vegetable Seeds, Inc.
 Seminis Vegetable Seeds, Inc. Agricultural Commodities/MillingProcess Industries Seminis Vegetable Seeds, Inc. engages in plant breeding research and development services. It develops types of vegetables, which are marketed to commercial vegetable growers, dealers, distributors, and wholesalers. The firm’s products include Fresh Market, Home Garden, Processor, Performance Series Sweet Corn, SummerSlice Watermelons and Pepper X10R and Technology. The company was founded in 1865 and is headquartered in St. Louis, MO. |
Agricultural Commodities/Milling
|
Bayer CropScience Ltd. (United Kingdom)
 Bayer CropScience Ltd. (United Kingdom) Chemicals: AgriculturalProcess Industries Bayer CropScience Ltd. manufactures and markets crop protection products. It offers fungicides, herbicides, insecticides, rodenticides and seeds. The firm also engages in the breeding, development, production, and marketing of hybrid seeds. The company is headquartered in Cambridge, the United Kingdom. |
Chemicals: Agricultural
|
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. |
Biotechnology
|
Intendis GmbH
 Intendis GmbH Pharmaceuticals: MajorHealth Technology Intendis GmbH specializes in dermatological drugs. Its products are to treat acne, rosacea, eczema, psoriasis, and fungal infections. The company operates in Austria, Brazil, France, Germany, Italy, Japan, Mexico, Poland, Portugal, Russia, Spain, Turkey, and the USA. It was founded in 2005 and is headquartered in Berlin, Germany. |
Pharmaceuticals: Major
|
Chemicals: Agricultural
|
Sector
Sales per Business
Sales per region
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +61.53% | 856B | |
| +38.95% | 631B | |
| -3.66% | 359B | |
| +15.06% | 325B | |
| +9.18% | 297B | |
| +5.89% | 234B | |
| +16.53% | 226B | |
| +15.67% | 177B | |
| +2.47% | 165B |
- Stock Market
- Equities
- BAYN Stock
- BAY Stock
- Company Bayer AG
